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Abstract 
Objective: This study aimed to compare the efficacy and safety of the newest bipolar vessel sealing system (BVSS; 
LigaSure™ Small Jaw) to that of conventional technique in axillary dissection.
Methods: Sixty-one patients with breast cancer were randomized to a conventional dissection surgical technique 
(CONV group; n = 30) by scalpel and monopolar cautery or that using a vessel sealing system (BVSS group; n = 31).
Results: There was a significant difference between both groups in the mean number of days until drain removal 
(6.4 ± 2.9 vs. 8.2 ± 3.8 days; P value = 0.033), and the mean total volume of drainage fluid (365.3 ± 242.2 vs. 
625.1 ± 446.6 mL; P value = 0.009). The incidence of seroma was similar in both groups (43.3 vs. 37.9 %; P value 
= 0.673). There was no statistically significant difference in axillary dissection operating time (66 vs. 70 min; P value 
= 0.371), or the mean volume of blood loss (18.2 ± 31.1 vs. 20.6 ± 26.3 mL; P value = 0.663).
Conclusions: Our results suggest that BVSS is a more effective device when compared to the conventional tech-
niques in axillary dissection.
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Background
Over the past several decades, there has been a strong 
trend toward minimizing the extent of surgical resection 
in the management of patients with breast cancer. Sen-
tinel lymph node biopsy (SLNB) has become the stand-
ard procedure for clinical node negative breast cancer 
surgery, and axillary lymph node dissection (ALND) is 
required much less frequently than earlier. However, 
ALND is still the standard procedure when aiming to 
control local recurrence and classify the tumor stage in 
patients with advanced breast cancer and multiple lymph 
node metastases. The number of involved lymph nodes 
has become an important prognostic factors that guide 
selection of those patients who might benefit from adju-
vant treatment (Clarke et  al. 2005; Orr 1999; Kodama 
et al. 2006; Fisher et al. 1985, 2002).
ALND is associated with postsurgical complications, 
such as lymphorrhea, seroma formation, lymphoedema 
and limited range of motion of the shoulder. Lymphor-
rhea occurrence and seroma formation is associated 
with delayed drain removal, prolonged in-hospital stay, 
and delayed adjuvant therapy. In the literature (Burak 
et al. 1997; Cortadellas et al. 2011; Gonzalez et al. 2003; 
Hashemi et  al. 2004; Agrawal et  al. 2006), frequency of 
seroma formation is reportedly 2.5–85 %. It has been sug-
gested that efficient methods of sealing blood and lymph 
vessels during ALND may play a key role in reducing 
postoperative lymphorrhea. Several new surgical devices, 
such as a harmonic scalpel and bipolar vessel sealing sys-
tem (BVSS), have been proposed. Several randomized 
controlled trials comparing harmonic scalpels or BVSS to 
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the conventional technique have reported on the efficacy 
of harmonic scalpels and BVSS, however, some trials 
concluded that there is no significant difference between 
these surgical devices (Burdette et al. 2011; Currie et al. 
2012; He et  al. 2012; Lumachi et  al. 2013; Iovino et  al. 
2012).
The LigaSure Small Jaw (LSJ; Covidien, Energy-Based 
Devices, Boulder, Colorado) is the newest BVSS in the 
LigaSure family, introduced in 2010. This device has fea-
tures like a small curved jaw, low-temperature profile, 
minimal thermal spread, and multifunctionality. There 
has been no prospective study comparing the LSJ with 
conventional surgical methods in ALND. In this study, 
we have conducted a prospective randomized trial com-




This study was designed as a prospective, open, single 
center, single blind randomized controlled trial. Study 
patients were recruited and underwent surgery in the 
surgical department of the Keio University Hospital. 
Patients were enrolled between May 2013 and June 2015 
and provided written informed consent before participat-
ing in the trial. Patients were randomly assigned to the 
study group (BVSS group) or the control group (con-
ventional treatment; CONV group) with a 1:1 ratio by 
using covariate adapting randomization. In the literature, 
several risk factors have been identified for seroma and 
lymphorrhea: age greater than 60  years, elevated body 
mass index (BMI), tumor size, neoadjuvant chemother-
apy, extent of gland resection, and number of metastatic 
lymph nodes. The patients were randomly assigned (1:1) 
to the BVSS or conventional group and balanced accord-
ing to age, BMI, type of surgery (i.e., breast conserving 
surgery or total mastectomy) and experience of surgeon 
(less or more 7  years). The investigating surgeons were 
informed of the treatment allocation via the randomiza-
tion software before they performed the procedures. The 
patients as well as the nurses who measured the daily 
drainage volumes were blinded to the group assignment. 
The BVSS group consisted of 31 patients who underwent 
ALND with the LigaSure Small jaw; the CONV group 
consisted of 30 patients who underwent ALND with con-
ventional devices such as mono or bipolar electrocautery.
Preoperative data such as breast cancer staging, age, 
and BMI were obtained for all patients. Several basic cri-
teria had to be met before patients were included in the 
study: (1) cytological proof of breast cancer, (2) curative 
surgery (mastectomy or breast-conserving surgery), (3) 
clinical N0 (no palpable axillary nodes) and confirmed to 
node positive via sentinel node biopsy, (4) N1 (metasta-
sis in movable ipsilateral axillary lymph node(s)) and N2 
(metastasis in fixed ipsilateral axillary lymph node(s) or 
in clinically apparent ipsilateral internal mammary lymph 
node(s) in the absence of clinically evident axillary lymph 
node metastasis) according to the 2009 UICC stage clas-
sification, 7th edition (UICC, 2009), (4) performance 
status 0–2 (ECOG scale) and (5) age over 20 years, and 
(6) patients who provided written informed consent. The 
exclusion criteria were: (1) a concomitant malignant dis-
ease, (2) prior surgery or radiotherapy for axilla and (3) 
patients with severe diabetes, infections, bleeding diath-
eses, or taking anticoagulant medication (e.g., aspirin and 
warfarin).
The study protocol was approved by the Ethical Com-
mittee of Keio University Hospital. The trial was reg-
istered at University hospital Medical Information 
Network (UMIN) Clinical Trial Registry with the ID 
number UMIN000010637.
Surgical technique and axillary drain
In all patients axillary lymphadenectomy was performed 
via standard level I and II en-bloc node dissection. The 
procedure was performed by a specialized breast surgi-
cal team, consisted of three senior breast surgeons and 
four junior breast surgeons in training. The senior sur-
geons supervised all the procedure of the surgery and 
postoperative management. Patients randomized to the 
BVSS group were operated using the LigaSure Small Jaw 
to seal the lymph and vessels; dissection with monopolar 
electrocautery or scalpel was limited as much as possible. 
Patients randomized to the CONV group were operated 
using scissors/scalpel and mono or bipolar electrocautery 
or suture ligation to achieve vessel sealing. The control of 
bleeding was achieved before a suction drain was intro-
duced in the axilla. At the end of the surgery, a closed 
suction drain (size: 5 mm) was placed in the axilla. In the 
case of total mastectomy, a closed suction drain (size: 
3 mm) was also placed in anterior chest. In all cases, the 
axillary dissection followed the breast surgery, and surgi-
cal time was recorded from the beginning of the axillary 
dissection to the end of surgery.
At the end of surgery, a standard, noncompressive 
dressing was applied to all patients. No limitation to arm 
movement was scheduled. According to protocol, the 
axillary drain was removed when the daily output was 
less than 30 mL in the previous 24 h. The total amount of 
drainage was measured daily during the hospital stay by 
the nursing staff, who were blinded to the devices used.
Patients were followed-up in out-patients clinic every 
one or 2 weeks for a minimum of 30 days after hospital 
discharge.
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Primary and secondary end points
The primary end point was to compare the days until 
drain removal on using the two different surgical tech-
niques. The secondary end points were to compare the 
total volume of fluid collected in the axillary drain, sur-
gical time, and the incidence of seroma in both groups. 
Safety of the experimental technique was judged by the 
occurrence of postoperative complications and intraop-
erative blood losses.
A sample size of 60 participants was calculated from 
our retrospective data before conducting this study. 
Assuming a difference in drainage volume between two 
groups with 90  % power and two-sided type I error of 
5 %, we required 60 patients with a drop out of 5 %. The 
mean days until drain removal after the axillary dissec-
tion using vessel sealing system versus electrocautery was 
6 versus 9 days (P = 0.208).
Statistical analysis
In all patients, the following data were recorded: age, 
BMI, type of surgery, previous neoadjuvant therapy, 
duration of operation, intraoperative blood loss meas-
ured as the amount of blood aspirated from the opera-
tive field and surgical gauzes (10 % blood-soaked gauge 
pieces weight), duration of drain placement, amount 
of drained fluid, length of hospital stay, number of 
punctures of axillary seromas in the outpatient clin-
ics, histological type and immunohistochemical char-
acteristics of the tumor, total number of lymph nodes 
excised, positive lymph nodes, and early postoperative 
complications (hematoma, wound infection, wound 
dehiscence, blood transfusion, and need for readmis-
sion). Continuous data were described according to 
median and range, and comparisons were performed 
by using the nonparametric Mann–Whitney U test. 
Categorical variables were described according to the 
percentages of subjects falling in each category, and 
analyzed by using the Chi square test. The hazard risk 
(HR) and the 95  % confidence interval (CI) were also 
obtained. An error level of P < 0.05 was considered sta-
tistically significant. The proportion of patients who 
reached 30  mL of daily output and had the drainage 
removed in time was described by using the Kaplan–
Meier estimate and compared by using the log-rank 
test. To examine the potential interactions between 
outcomes and patients’ background, subgroup analysis 
was performed.
Statistical analysis of the data was performed by using 
SPSS® Version 20 (SPSS-IBM Inc., Chicago, IL, USA). A 
value of P < 0.05 was considered statistically significant, 
and all tests were 2-sided. This trial is reported in accord-
ance with the CONSORT statement.
Fig. 1 Trial profile
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Table 1 Characteristics of patients
Variables Vessel sealing system (BVSS) Conventional devices (CONV) P value
Number of patients 31 30
Age at diagnosis (y/o) 59.1 ± 15.6 57.6 ± 11.2 0.663
BMI 21.8 ± 4.0 21.5 ± 3.1 0.731
Comorbidities
 HTN 5 (16.1 %) 2 (6.7 %) 0.246
 DM 2 (6.5 %) 1 (3.3 %) 0.573
 Smoking 11 (35.5 %) 4 (13.3 %) 0.045
Clinical TNM stage 0.055
 0 0 (0.0 %) 1 (3.3 %)
 1 8 (26.7 %) 1 (3.3 %)
 2 18 (60.0 %) 21 (70.0 %)
 3 4 (13.3 %) 7 (23.3 %)
Clinical T stage 0.111
 Tis 0 (0.0 %) 1 (3.3 %)
 T1 11 (35.5 %) 3 (10.0 %)
 T2 16 (51.6 %) 20 (66.7 %)
 T3 1 (3.2 %) 2 (6.7 %)
 T4 3 (9.7 %) 4 (13.3 %)
Clinical N stage 0.73
 N0 11 (35.5 %) 9 (30.0 %)
 N1 17 (54.8 %) 19 (63.3 %)
 N2 1 (3.2 %) 0 (0.0 %)
 N3 2 (6.5 %) 2 (6.7 %)
Neoadjuvant chemotherapy 21 (67.7 %) 24 (80.0 %) 0.277
Receptor status
 Hormone receptor positive 19 (61.3 %) 12 (40.0 %) 0.286
 HER2 positive 4 (13.3 %) 10 (24.1 %) 0.047
Histology 0.331
 Ductal carcinoma 31 (100 %) 28 (96.5 %)
 Lobular carcinoma 0 (0.0 %) 1 (3.4 %)
 Others 0 (0.0 %) 1 (3.4 %)
Nuclear grade 0.679
 1 11 (35.5 %) 13 (43.3 %)
 2 10 (32.3 %) 7 (23.3 %)
 3 7 (22.6 %) 5 (16.7 %)
 Unknown 3 (9.7 %) 5 (16.7 %)
Type of surgery 0.394
 Total mastectomy 18 (58.1 %) 18 (60.0 %)
 Breast conserving surgery 12 (38.7 %) 12 (40.0 %)
Total number of removed lymph nodes 20.3 ± 7.4 18.4 ± 6.7 0.268
Pathological tumor size 2.1 ± 1.6 1.7 ± 1.3 0.290
Total number of pathologically
Positive lymph nodes 0.273
 0 9 (29.0 %) 10 (33.3 %)
 1 7 (22.6 %) 10 (33.3 %)
 2 7 (22.6 %) 4 (13.3 %)
 3 1 (3.2 %) 4 (13.3 %)
 >4 7 (22.6 %) 2 (6.6 %)
Lymphovascular invasion 16 (51.6 %) 12 (40.0 %) 0.363
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Results
Background characteristics of the patients
During the study period, 81 patients underwent axillary 
lymph node dissection out of a total of 418 breast can-
cer patients. Among these, 61 patients were enrolled and 
randomized, with 31 in the BVSS group and 30 in the 
CONV group. No patient was excluded after randomi-
zation, and no one was lost to follow up. Finally, a total 
of 31 patients in the BVSS group, and 30 patients in the 
CONV group were analyzed on an intention-to-treat 
basis (Fig. 1). The baseline characteristics of the patients 
are summarized in Table  1. There were no statistically 
significant differences between the two groups, except for 
the HER2 status.
Intraoperative data
Overall, 36 (59.0  %) patients underwent total mastec-
tomy, while 24 (39.3  %) patients underwent breast-con-
serving surgery (partial mastectomy), according to the 
tumor stage. One patient who was diagnosed with acces-
sory breast cancer underwent axillary dissection only. 
There was no significant difference in type of surgery 
between the two groups. There was no significant statisti-
cal difference in the axillary dissection operating time (66 
vs. 70 min; P value = 0.371), or the mean volume of blood 
loss (18.2 ± 31.1 vs. 20.6 ± 26.3 mL; P value = 0.663).
Postoperative data
The postoperative data is shown in Figs. 2, 3, 4. As shown 
in Fig.  2, there was a significant difference between the 
two groups in mean number of days until removal of the 
drain (6.4 ± 2.9 vs. 8.2 ± 3.8 days; P value = 0.033). The 
proportion of patients who reached 30 mL of daily out-
put and had the drain removed in time was described by 
using the Kaplan–Meier estimate and compared by using 
the log-rank test (Fig.  3). The days until drain removal 
were significantly reduced in the BVSS group (P value 
= 0.022). The mean total volume of drainage was also sig-
nificantly reduced in the BVSS group (365.3 ± 242.2 vs. 
625.1 ±  446.6  mL; P value =  0.009) (Fig.  4). The mean 
number days of postoperative hospital stay was not sig-
nificantly reduced in the BVSS group (8.8  ±  3.1 vs. 
10.1 ± 3.1 days; P value = 0.077).
Complications
Short-term postoperative complications (i.e., bleeding 
and hematoma) were observed in 1 (3.3 %) patients in the 
conventional group. None of the patients in either group 
developed wound infections or experienced skin burns 
or necrosis. Twenty-four (39.3 %) patients developed an 
axillary seroma: 13 (43.3 %) and 11 (37.9 %) in the BVSS 
and CONV groups, respectively (P value = 0.673).
Subgroup analysis
We performed a subgroup analysis to identify poten-
tial interactions between drain days and patients’ back-
ground factors (Fig.  5), and between drainage volume 
and patients’ background factors (Table 2). A significant 
risk reduction for the days until drain removal was noted 
in the BVSS group compared to the CONV group in 
patients with age under 60 years, BMI less than 25, and 
patients whose surgeries were performed by the surgeon 
with more than 7 years of experience. A significant drain-
age volume reduction was also noted in the BVSS group 
compared to the CONV group in these same patients.
Discussion
An advantage of using the vessel sealing system is that 
this procedure does not require direct exposure of blood 
vessels, which can increase operative time and cause 
Table 1 continued
Variables Vessel sealing system (BVSS) Conventional devices (CONV) P value
Mean days until drain removal 6.4 ± 2.9 8.2 ± 3.8 0.033
Total drain volume (mL) 365.3 ± 242.2 625.1 ± 446.6 0.009
Total operating times (minutes) 180.9 ± 65.5 168.6 ± 30.3 0.670
Axillary dissection operating time (minutes) 65.6 ± 19.6 70.3 ± 21.6 0.371
Estimated blood loss (mL) 18.2 ± 31.1 20.6 ± 26.3 0.663
Postoperative complications 0.673
 Postoperative bleeding 0 (0.0 %) 1 (3.3 %)
 Hematoma 0 (0.0 %) 1 (3.3 %)
 Seroma 13 (43.3 %) 11 (37.9 %)
 Wound infection 0 (0.0 %) 0 (0.0 %)
 Flap necrosis 0 (0.0 %) 0 (0.0 %)
 Skin burn 0 (0.0 %) 0 (0.0 %)
Postoperative hospital stay (days) 8.8 ± 3.1 10.1 ± 3.1 0.077
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unnecessary bleeding. Previous randomized studies 
comparing the vessel sealing system with conventional 
devices have reported that vessel sealing system seems to 
reduce the drainage volume and shorten the postopera-
tive hospital days (Cortadellas et  al. 2011; Nespoli et  al. 
2012; Tukenmez et  al. 2014). The vessel sealing system 
used in these studies was the LigaSure Precise, not the 
newest device, the LigaSure Small Jaw.
The LigaSure Small Jaw is a manual device, 18.8  cm 
long. It is designed to be used in confined surgical spaces 
where access and visibility are limited. This instrument, 
designed for open surgery, offers the ability to selectively 
cut or grasp tissue and permanently seal vessels with a 
diameter of up to and including 7  mm, lymphatic ves-
sels, and tissue bundles without using sutures, staples, 
or clips. Although some studies (Yoshimoto et  al. 2014; 
Hwang et  al. 2014; Coiro et  al. 2015) comparing the 
LigaSure Small Jaw with conventional suture ligation in 
thyroidectomy and hepatic resection showed intraopera-
tive blood loss to be statistically significantly less for the 
LigaSure Small Jaw, this device had not yet been evalu-
ated in axillary dissection. To the best of our knowledge, 
our study is the first randomized controlled study com-
paring the LigaSure Small Jaw and conventional devices 
in axillary dissection. Our study shows that the use of the 
LigaSure Small Jaw reduced the days until drain removal 
and postoperative drainage volume when comparing to 
the conventional devices. It is extremely important to 
shorten drain days and hospital stay, because delays in 
these factors can lead to delays in adjuvant therapy. In 
this study, after subgroup analysis, the vessel sealing sys-
tem seems to be more effective in the patients with age 
under 60 years, and BMI less than 25. However this was 
not conclusive because of the limited sample size.
Although drainage days were reduced on using the ves-
sel sealing system, seroma formation could not be com-
pletely avoided. The optimal way to prevent and treat 
seromas remains inconclusive. Other complications such 
as postoperative bleeding and skin flap necrosis were not 
Fig. 2 Distribution of the drain days. There was a significant differ-
ence between the two groups in the mean number of days until 
drain removal (6.4 ± 2.9 vs. 8.2 ± 3.8 days; P value = 0.033). Boxplot 
legend: upper horizontal line of box 75th percentile, lower horizontal 
line of box 25th percentile, horizontal bar within box median value and 
vertical dotted line minimum–maximum value. BVSS bipolar vessel 
sealing system, CONV conventional devices
Fig. 3 Cumulative percentage of patients with the drain removed 
over time. The proportion of patients who reached 30 mL of daily 
output and had the drain removed in time was described by using 
the Kaplan–Meier estimate and compared by using the log-rank test. 
Drain days were significantly reduced in the BVSS group (P = 0.022). 
BVSS bipolar vessel sealing system, CONV conventional devices
Fig. 4 Distribution of the total drainage volume. There was a signifi-
cant difference between the two groups in the mean total volume of 
drainage fluid (365.3 ± 242.2 vs. 625.1 ± 446.6 mL; P value = 0.009). 
Boxplot legend: upper horizontal line of box 75th percentile, lower 
horizontal line of box 25th percentile, horizontal bar within box median 
value and vertical dotted line minimum–maximum value. BVSS bipolar 
vessel sealing system, CONV conventional devices
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observed when the vessel sealing system was used. No 
statistically significant difference was seen in intraopera-
tive blood loss on use of the vessel sealing system com-
pared to use of conventional devices. We can conclude 
that the vessel sealing system is safe to use in axillary dis-
section. On the other hand, a major criticism of the vessel 
sealing system seems to be its high cost. However, when 
taking the discomfort of postoperative drain days into 
consideration, the device actually might be cost-effective 
for patients.
This is a randomized controlled study with a well-
planned consistent protocol of peri-operative care, data 
management, and statistical analysis. Patients were 
strictly followed up until the end of the study. Although 
randomized controlled studies are usually the highest 
level of evidence for judging the efficacy of therapeutic 
interventions, a limitation of this study is that it is not 
possible to blind the operating surgeon on the result of 
randomization which could influence the outcome of the 
study. Another limitation is the low patient population in 
this study. This study was conducted in a single institu-
tion and was therefore not adequately powered to assess 
the benefit of treatment in different subgroups.
In conclusion, this study suggested the usefulness of the 
vessel sealing system in axillary dissection. This device 
reduces the duration until drain removal and total drain-
age volume, and the complication rates were comparable 
to those seen on using conventional devices.
Fig. 5 Subgroup analysis of drain days. Subgroup analysis was performed by using the Cox hazard ratio analysis. Hazard ratio and 95 % confidence 
interval was obtained. Drain days were reduced in the patients with age under 60 years, body mass index less than 25, and patients whose surgery 
was performed by the surgeon with more than 7 years of experience. BVSS bipolar vessel sealing system, CONV conventional devices
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Total 365 ± 242 625 ± 447 0.006
Age
 <60 years 293 ± 144 612 ± 438 0.02
 ≧60 years 425 ± 291 637 ± 468 0.146
BMI
 <25 304 ± 179 594 ± 415 0.005
 ≧25 620 ± 317 828 ± 657 0.517
Tumor size
 T1, T2 388 ± 330 648 ± 438 0.011
 T3, T4 211 ± 107 534 ± 511 0.476
Nodal status
 Negative 410 ± 295 774 ± 475 0.175
 Positive 341 ± 212 561 ± 430 0.046
Neoadjuvant 
therapy
 Yes 374 ± 310 868 ± 511 0.011
 No 361 ± 211 564 ± 419 0.092
Breast surgery
 Mastectomy 346 ± 180 505 ± 396 0.265
 Breast-conserving 
therapy
412 ± 321 805 ± 473 0.02
Experience of 
surgeon
 <7 years 530 ± 441 691 ± 558 0.642
 ≧7 years 341 ± 201 608 ± 427 0.007
